Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IGFBP3 Antikörper (Internal Region)

IGFBP3 Reaktivität: Human, Maus, Ratte, Hund WB Wirt: Ziege Polyclonal unconjugated
Produktnummer ABIN374871
  • Target Alle IGFBP3 Antikörper anzeigen
    IGFBP3 (Insulin-Like Growth Factor Binding Protein 3 (IGFBP3))
    Bindungsspezifität
    • 15
    • 11
    • 9
    • 8
    • 7
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region
    Reaktivität
    • 101
    • 42
    • 33
    • 5
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Human, Maus, Ratte, Hund
    Wirt
    • 102
    • 15
    • 1
    • 1
    Ziege
    Klonalität
    • 103
    • 16
    Polyklonal
    Konjugat
    • 63
    • 15
    • 7
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser IGFBP3 Antikörper ist unkonjugiert
    Applikation
    • 102
    • 48
    • 46
    • 17
    • 13
    • 13
    • 8
    • 7
    • 7
    • 5
    • 5
    • 2
    • 1
    • 1
    Western Blotting (WB)
    Sequenz
    C-RYKVDYESQS TDTQN
    Spezifität
    This antibody detects IGFBP3. It is expected to recognise both reported isoforms (NP_001013416.1 and NP_000589.2).
    Kreuzreaktivität (Details)
    Species reactivity (expected):Mouse, Rat, DogSpecies reactivity (tested):Human
    Aufreinigung
    Ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide
    Immunogen
    Peptide from the internal region of the protein sequence according to NP_001013416.1, NP_000589.2.
    Top Product
    Discover our top product IGFBP3 Primärantikörper
  • Applikationshinweise
    Peptide ELISA: antibody detection limit dilution 1: 64000. Western blot: 0.02-0.06 μg/mL. Approx 28 kDa band observed in Human Breast cancerlysates (calculated MW of 31.8 kDa according to NP_001013416.1 and 32.8 kDa according toNP_000589.2). An additional band of 58 kDa was consistently observed, however this bandwas not blocked by the immunizing peptide and it is therefore a non-specific signal. Wecall for caution when used for other assays than Western blot.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    0.5 mg/mL
    Buffer
    Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
  • Target
    IGFBP3 (Insulin-Like Growth Factor Binding Protein 3 (IGFBP3))
    Andere Bezeichnung
    IGFBP3 (IGFBP3 Produkte)
    Synonyme
    BP-53 antikoerper, IBP3 antikoerper, AI649005 antikoerper, IGFBP-3 antikoerper, IGgfbp3 antikoerper, IGF-BP3 antikoerper, zgc:91788 antikoerper, IGFBP3 antikoerper, igfbp3 antikoerper, insulin like growth factor binding protein 3 antikoerper, insulin-like growth factor binding protein 3 antikoerper, IGFBP3 antikoerper, Igfbp3 antikoerper, igfbp3 antikoerper, IGFBP-3 antikoerper, LOC100305016 antikoerper
    Hintergrund
    Insulin like growth factor binding protein 3 (IGFBP3) is a member of the superfamily of insulin like growth factor (IGF) binding proteins which include six high affinity IGF binding proteins (IGFBP) and at least four low affinity binding proteins referred to as IGFBP related proteins (IGFBPrP). The IGFBP members are cysteine rich proteins with conserved cysteine residues clustered in the amino terminal and the carboxy terminal regions of the molecule. The cDNA sequence encoding the mature human IGFBP3 is fused to the signal peptide of CD33. Human IGFBP3 is the major IGF binding protein in plasma where it exists in a ternary complex with IGFI or IGFII and an acid labile subunit. IGFBPs hold a central position in IGF ligand-receptor interactions through influences on both the bioavailability and distribution of IGFs in the extracellular environment. Insulin like growth factor binding protein 3 (IGFBP3) can modulate the mitogenic and metabolic effects of the insulin like growth factors (IGFs). Insulin like growth factor binding protein 3 (IGFBP3) is expressed in multiple tissues. The highest expression level is found in the non paranchymal cells of the liver. The expression levels are higher during extrauterine life and peak during puberty. Insulin like growth factors (IGFs) and IGF binding proteins (IGFBPs) play important roles in cell growth and differentiation. IGFBP3 is one of the factors in serum that is responsible for high serum induced apoptosis in PC3 cells, a prostate cancer cell line. IGFBP3 is important in controlling glucose homeostasis with increased urinary levels in type I diabetes with persistent microalbuminuria.Synonyms: IBP-3, IBP3, IGF-BP3, IGF-binding protein 3, IGFBP-3, Insulin-like growth factor-binding protein 3
    Gen-ID
    3486, 9606
    UniProt
    P17936
    Pathways
    Myometrial Relaxation and Contraction, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Autophagie, Smooth Muscle Cell Migration, Growth Factor Binding
Sie sind hier:
Kundenservice